CSIMarket
 


Pluristem Therapeutics Inc  (PSTI)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Pluristem Therapeutics Inc's Working Capital Ratio

PSTI's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




PSTI Working Capital Ratio (Dec 31 2019)
II. Quarter
(Sep 30 2019)
I. Quarter
(Jun 30 2019)
IV. Quarter
(Mar 31 2019)
III. Quarter
(Dec 31 2018)
II. Quarter
Y / Y Current Liabilities Change -16.69 % -7.02 % -4.56 % 5.64 % 24.79 %
Y / Y Current Assets Change 4.76 % -12.19 % -17.68 % -63.04 % -50.49 %
Working Capital Ratio MRQ 3.19 3.12 3.23 1.6 2.54
Overall Ranking # 253 # 1185 # 1359 # 2362 # 1860
Seq. Current Liabilities Change -12.39 % -15.68 % -1.08 % 14 % -2.22 %
Seq. Current Assets Change -10.45 % -18.58 % 99.84 % -28.1 % -24.94 %



Working Capital Ratio second quarter 2019 Comment
Current Liabilities decreased faster than Pluristem Therapeutics Inc's Current Assets, this led to improvement in Pluristem Therapeutics Inc's Working Capital Ratio to 3.19, Working Capital Ratio remained below Pluristem Therapeutics Inc average.

Within Biotechnology & Drugs industry 17 other companies have achieved higher Working Capital Ratio than Pluristem Therapeutics Inc in second quarter 2019. While Working Capital Ratio total ranking has improved so far to 253, from total ranking in previous quarter at 1185.

Explain Working Capital Ratio
Where is PSTI most successful ?
Working Capital Ratio PSTI on the trailing twelve month basis
Working Capital Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 18
Healthcare Sector # 53
Overall Market # 253


Working Capital Ratio Statistics
High Average Low
13.38 7.17 1.6
(Sep 30 2012)   (Mar 31 2019)




Financial Statements
Pluristem Therapeutics Inc's Current Liabilities $ 6 Millions Visit PSTI's Balance sheet
Pluristem Therapeutics Inc's Current Assets $ 19 Millions Visit PSTI's Balance sheet
Source of PSTI's Sales Visit PSTI's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingDec 31 2019, within Biotechnology & Drugs Industry Working Capital RatioDec 31 2019 MRQ Current AssetsDec 31 2019 MRQ Current Liabilities
Delmar Pharmaceuticals, Inc.  8.66 $ 6.502  Millions$ 0.751  Millions
Evelo Biosciences, Inc.  8.31 $ 81.009  Millions$ 9.743  Millions
Nexien Biopharma, Inc.  7.94 $ 0.147  Millions$ 0.019  Millions
Cannabics Pharmaceuticals Inc.  6.90 $ 3.041  Millions$ 0.441  Millions
Genocea Biosciences, Inc.  6.62 $ 41.584  Millions$ 6.281  Millions
Quotient Ltd  6.43 $ 166.719  Millions$ 25.930  Millions
Anavex Life Sciences Corp.  5.75 $ 31.424  Millions$ 5.464  Millions
Bluebird Bio, Inc.  5.15 $ 1,152.174  Millions$ 223.580  Millions
Seattle Genetics Inc  4.54 $ 1,176.641  Millions$ 259.357  Millions
Bio-techne Corp  4.43 $ 465.074  Millions$ 104.953  Millions
Meridian Bioscience Inc  4.37 $ 152.432  Millions$ 34.853  Millions
Applied Genetic Technologies Corp  4.33 $ 64.717  Millions$ 14.931  Millions
Pluristem Therapeutics Inc  3.19 $ 19.227  Millions$ 6.027  Millions
Myriad Genetics, Inc.  3.18 $ 365.300  Millions$ 115.000  Millions
Cel Sci Corp  2.72 $ 12.418  Millions$ 4.566  Millions
Urovant Sciences Ltd.  2.32 $ 142.457  Millions$ 61.534  Millions
Vitality Biopharma, Inc.  2.26 $ 3.137  Millions$ 1.390  Millions
Cyanotech Corp  2.10 $ 14.820  Millions$ 7.059  Millions
Quidel Corp  1.77 $ 222.227  Millions$ 125.891  Millions
Biogen Inc.  1.72 $ 8,381.800  Millions$ 4,863.800  Millions
Neurocrine Biosciences, Inc.  1.47 $ 831.034  Millions$ 565.287  Millions
Amgen Inc.  1.44 $ 18,440.000  Millions$ 12,835.000  Millions
Integrated Biopharma Inc  1.18 $ 14.536  Millions$ 12.293  Millions
Aytu Bioscience, Inc  1.15 $ 18.338  Millions$ 15.950  Millions
Axovant Gene Therapies Ltd.  1.09 $ 33.421  Millions$ 30.688  Millions
Allergan Plc  1.01 $ 11,126.700  Millions$ 11,070.700  Millions
Citius Pharmaceuticals, Inc.  0.80 $ 2.892  Millions$ 3.630  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

MCFT's Profile

Stock Price

MCFT's Financials

Business Description

Fundamentals

Charts & Quotes

MCFT's News

Suppliers

MCFT's Competitors

Customers & Markets

Economic Indicators

MCFT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071